Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.88)
# 3,236
Out of 4,996 analysts
207
Total ratings
24.53%
Success rate
-2.84%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.08 | +733.33% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.65 | +1,138.20% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.54 | +242.96% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.23 | +79.37% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.99 | -33.11% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.49 | +1,526.35% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.95 | +544.07% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.49 | +743.37% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.73 | +767.05% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $0.75 | +7,343.84% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.61 | +1,550.17% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.46 | +334.78% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $5.51 | +444.46% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.55 | +122.22% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.69 | +494.80% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.10 | +445.45% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.15 | +8,595.65% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.63 | +2,779.54% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.74 | +1,049.43% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $5.24 | +300,432.37% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $18.93 | +2,541.31% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $22.40 | +971.67% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.85 | +4,224.32% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.78 | +12,801.56% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $7.26 | +110,092.84% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.29 | +442.64% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.39 | +1,155.23% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.01 | +1,228.90% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $8.95 | +101.12% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.55 | +9.89% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $4.90 | +29,287.76% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $50.40 | -52.38% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.40 | +244,185.71% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.84 | +1,032,508.70% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.08
Upside: +733.33%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.65
Upside: +1,138.20%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.54
Upside: +242.96%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.23
Upside: +79.37%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.99
Upside: -33.11%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.49
Upside: +1,526.35%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.95
Upside: +544.07%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.49
Upside: +743.37%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.73
Upside: +767.05%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $0.75
Upside: +7,343.84%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $0.61
Upside: +1,550.17%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.46
Upside: +334.78%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $5.51
Upside: +444.46%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.55
Upside: +122.22%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.69
Upside: +494.80%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.10
Upside: +445.45%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.15
Upside: +8,595.65%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.63
Upside: +2,779.54%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.74
Upside: +1,049.43%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $5.24
Upside: +300,432.37%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $18.93
Upside: +2,541.31%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $22.40
Upside: +971.67%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.85
Upside: +4,224.32%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.78
Upside: +12,801.56%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $7.26
Upside: +110,092.84%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.29
Upside: +442.64%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.39
Upside: +1,155.23%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.01
Upside: +1,228.90%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $8.95
Upside: +101.12%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $4.55
Upside: +9.89%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $4.90
Upside: +29,287.76%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $50.40
Upside: -52.38%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.40
Upside: +244,185.71%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.84
Upside: +1,032,508.70%